This analysis identified several drugs, such as Docetaxel_1007 (Figure 9B), Dactolisib_1057 (Figure 9C), Lapatinib_1558 (Figure 9D), and Tamoxifen_1199 (Figure 9E), with their sensitivity correlating with CTU2 expression levels, demonstrating a cancer-type-dependent response. The gene discussed is CTU2; the disease is cancer.